To: All persons and/or entities who purchased common stock in KaloBios Pharmaceuticals, Inc. [NASDAQ: KBIO] during the period from November 18, 2015 to December 16, 2015, and were damaged thereby; a settlement has been announced in the securities litigation known as In re KaloBios Pharmaceuticals, Inc. Securities Litigation, Case No. 5:15-cv-05841, United States District Court for the Northern District of California.. For additional information about this settlement, please see the Notice and Proof of Claim (links provided below):
Claim submission deadline is April 6, 2017.
If you have any questions about the settlement, please contact the Claims Administrator. Their contact information can be found in the attached Notice.
Contact Us for
10205 North Pennsylvania Avenue, Oklahoma City, Oklahoma 73120Ph: 405.235.1560 Fax: 405.239.2112
Copyright © 2017 Federman & Sherwood. All Rights Reserved.